热门资讯> 正文
X4 Pharmaceuticals获得6000万美元PIPE融资
2025-08-12 21:49
- X4 Pharmaceuticals (NASDAQ:XFOR) has entered into a $60 million PIPE financing deal, expected to close around August 13, 2025, pending customary conditions.
- The company will issue 11,040,776 shares at $1.42 each, or pre-funded warrants for up to 31,234,731 shares at $1.419 each, with a $0.001 exercise price and no expiration.
- Proceeds will fund further development of mavorixafor for chronic neutropenia and support the commercialization of WHIM.
- X4 Pharmaceuticals shares rose 30%.
More on X4 Pharmaceuticals
- X4 Pharmaceuticals gains on fast-track designation for mavorixafor for treatment of chronic neutropenia
- Seeking Alpha’s Quant Rating on X4 Pharmaceuticals
- Historical earnings data for X4 Pharmaceuticals
- Financial information for X4 Pharmaceuticals
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。